Inheritedforms of distal renal tubular acidosis (dRTA) have been linkedto mutations in the human gene encoding the AE1 Cl/HCO3exchanger (SLC4A1). A mouse knockout model lacking AE1 (slc4a1/)described by Stehberger et al. has autosomal recessive classicaldRTA with hyperchloremic metabolic acidosis, low net acid excretion,and inappropriately alkaline urine without bicarbonaturia. BasolateralCl/HCO3 exchange activity in acid-secretory intercalatedcells of isolated perfused slc4a1/ cortical collectingduct was reduced, but alternate bicarbonate transport pathway(s)were upregulated. The heterozygote mice (slc4a1/+) hadno apparent defect in acidification, whereas the homozygousmice had dRTA and nephrocalcinosis associated with hypercalciuria,hyperphosphaturia, and hypocitraturia. The slc4a1/mouse is the first genetic model of complete dRTA and demonstratesthat the AE1 Cl/HCO3 exchanger is required formaintenance of normal acidbase homeostasis with distalrenal regeneration of bicarbonate as a critical part of netacid excretion in the mouse as well as humans. See Stehbergeret al., pages 14081418.
mPGES1, a New Player in the Renal Prostaglandin Story with Unique Gender Specificity.
Prostaglandinsare recognized as important modulators of renal hemodynamicsand salt and water balance, but the relative roles of individualprostaglandin types in these physiologic responses remain controversial.Although cyclooxygenase is the rate-limiting enzyme involvedin producing PGH2, the common prostaglandin precursor, specificsynthetases synthesize the individual prostaglandin types. ForPGE2 synthesis, mPGES1 has gained attention because it is responsiblefor the late phase of PGE2 synthesis during inflammation andis linked to cyclooxygenase-2 expression. However, in the kidneymPGES1 is also expressed constitutively in nephron segmentsthat express high levels of cyclooxygenase-1. Utilizing mPGES1-deficientmice, Francois et al. now report an important role for mPGES1in basal renal PGE2 synthesis but surprising gender-linked differencesin the relative roles of mPGES1 and PGE2 to mediate kidney function.See Francois et al., pages 14661475.
The Permeability Factor in Minimal ChangeHave We Finally Found It?
The conceptthat minimal change nephrotic syndrome (MCNS) is caused by acirculating lymphocyte-derived permeability factor acting onglomerular podocytes has been prevalent since it was first proposedby Shalhoub in 1974, but verification of his hypothesis andidentification of the factor have been extremely elusive. Inthis study, IL13 transfection in rats produced clinical manifestationsof nephrotic syndrome with normal glomerular histology, downregulationof some podocyte-specific proteins, and foot process effacementby electron microscopy, which are all features that mimic MCNS.Although proteinuria in transfected animals was modest and circulatingIL 13 was elevated almost 100-fold, the model described is excitingand represents the closest anyone has come yet to reproducingMCNS with an endogenous factor in an animal model. More studieswill be necessary to determine whether IL13 is elevated andhas similar effects in man, but the potential of this paperto advance an area in which progress has been disappointingseems very high. See Lai et al., pages 14761485.
This reportby de Zeeuw et al. of a post hoc analysis of the Reduction ofEndpoints in NIDDM with the Angiotensin II Antagonist Losartan(RENAAL) studies addresses an increasingly important issue inthe management of albuminuric chronic kidney disease. The authorshave examined the joint and independent contributions of reductionof blood pressure and albuminuria in the risk of progressionto ESRD. They report that reductions in albuminuria and sytolicBP (SBP) were independent predictors for ESRD and that no interactionbetween the two treatment effects was observed. Finally, inadjusted analyses the reduction of SBP was no longer significantlyassociated with risk after adjusting for other risk factors.These observations, in concert with other analyses that supportproteinuria or albuminuria reduction as a therapeutic target,are as yet insufficient evidence to recommend changes in themanagement of chronic kidney disease patients with proteinuria.Until such evidence is forthcoming, we should proceed with cautionwhen treating proteinuria in patients who have achieved targetBP of 130/80 mmHg. See Eijkelkamp et al., pages 15401546.
Mutations of Nephronophthisis Genes in Joubert Syndrome.
Joubertsyndrome is an inherited neurologic disorder that is characterizedby cerebellar vermis hypoplasia, which produces the molar toothsign on brain imaging studies. Twenty-five percent of patientswith Joubert syndrome also develop kidney abnormalities thatare similar to those found in nephronophthisis. Tory and colleaguesscreened 28 families with nephronophthisis and neurologic symptomsfor mutations in genes that cause nephronophthisis or Joubertsyndrome. Mutations of two nephronophthisis genes, NPHP1 orNPHP6, were found in two thirds of patients. Several patientswith two NPHP1 mutations also carried heterozygous mutationsof NPHP6 or heterozygous mutations of the Joubert syndrome diseasegene AHI1. Taken together, these studies identify a high rateof nephronophthisis gene mutations in individuals with Joubertsyndrome and nephronophthisis. Epistatic interactions involvingmultiple NPHP and Joubert syndrome genes may explain why somepatients with nephronophthisis present with neurologic symptoms,whereas others present with only kidney disease. See Tory etal., pages 15661575.
Using the Dialysis Unit as an Exercise ClubIt Seems to Work!
Skeletal muscle wasting (sarcopenia) is a common, insidious,and debilitating complication that afflicts hemodialysis patients.Although low levels of physical activity have been demonstratedto contribute to muscle atrophy, it is less clear whether musclequality and quantity can be improved through increased muscleuse such as with exercise resistance training. In this issueof JASN, Cheema and colleagues performed a clinical trial inwhich 49 patients were randomized to receive high-intensityprogressive resistance training or usual care only for a 12-wkperiod. Although there was no significant change in the primaryoutcome (thigh muscle cross-sectional area), there were significantimprovements in important secondary end points (muscle strength,muscle attenuation, mid-thigh circumference, and C-reactiveprotein) in the progressive resistance training group. Thesedata suggest that intensive resistance training during routinehemodialysis treatment sessions can improve muscle quality andpossibly lead to other health-related improvements. See Cheemaet al., pages 15941601.
An Explanation for Racial Disparities in Kidney Transplant Outcomes.
African-Americanrace and prolonged time on dialysis are established risk factorsfor poor outcome after kidney transplantation, but the reasonsremain obscure. Augustine and colleagues evaluated the strengthof pretransplant cellular anti-donor immunity and correlatedthe findings with outcomes, race, and dialysis vintage. Stronganti-donor immunity pretransplantation was positively associatedwith a significantly longer time on dialysis and a higher rateof posttransplantation acute rejection. Median time on dialysiswas three-fold higher in African-American recipients versuscontrols. Multivariate analysis revealed that time on dialysiswas a positive correlate of anti-donor immunity independentof ethnicity. Overall, the data suggest that the risk of developingpotent anti-donor T cell immunity increases with longer hemodialysisvintage regardless of ethnicity, which provides a possible explanationfor the relationship between increased dialysis exposure andworse posttransplant outcomes. Longer time on dialysis may alsoexplain the increased T cell alloreactivity and worse outcomespreviously observed in African-American kidney recipients. SeeAugustine et al., pages 16021606.
Related Articles
Role of Microsomal Prostaglandin E Synthase 1 in the Kidney
Helene Francois, Carie Facemire, Anil Kumar, Laurent Audoly, Beverly Koller, and Thomas Coffman
J. Am. Soc. Nephrol. 2007 18: 1466-1475.
[Abstract][Full Text][PDF]
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial
Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Hans-Henrik Parving, Mark E. Cooper, William F. Keane, Shahnaz Shahinfar, Gilbert W. Gleim, Matthew R. Weir, Barry M. Brenner, and Dick de Zeeuw
J. Am. Soc. Nephrol. 2007 18: 1540-1546.
[Abstract][Full Text][PDF]
Overexpression of Interleukin-13 Induces Minimal-ChangeLike Nephropathy in Rats
Kin-Wai Lai, Chang-Li Wei, Li-Kiang Tan, Puay-Hoon Tan, Gilbert S.C. Chiang, Caroline G.L. Lee, Stanley C. Jordan, and Hui-Kim Yap
J. Am. Soc. Nephrol. 2007 18: 1476-1485.
[Abstract][Full Text][PDF]
Distal Renal Tubular Acidosis in Mice Lacking the AE1 (Band3) Cl/HCO3 Exchanger (slc4a1)
Paul A. Stehberger, Boris E. Shmukler, Alan K. Stuart-Tilley, Luanne L. Peters, Seth L. Alper, and Carsten A. Wagner
J. Am. Soc. Nephrol. 2007 18: 1408-1418.
[Abstract][Full Text][PDF]
Hemodialysis Vintage, Black Ethnicity, and Pretransplantation Antidonor Cellular Immunity in Kidney Transplant Recipients
Joshua J. Augustine, Emilio D. Poggio, Michael Clemente, Mark I. Aeder, Kenneth A. Bodziak, James A. Schulak, Peter S. Heeger, and Donald E. Hricik
J. Am. Soc. Nephrol. 2007 18: 1602-1606.
[Abstract][Full Text][PDF]
High NPHP1 and NPHP6 Mutation Rate in Patients with Joubert Syndrome and Nephronophthisis: Potential Epistatic Effect of NPHP6 and AHI1 Mutations in Patients with NPHP1 Mutations
Kálmán Tory, Tiphanie Lacoste, Lydie Burglen, Vincent Morinière, Nathalie Boddaert, Marie-Alice Macher, Brigitte Llanas, Hubert Nivet, Albert Bensman, Patrick Niaudet, Corinne Antignac, Rémi Salomon, and Sophie Saunier
J. Am. Soc. Nephrol. 2007 18: 1566-1575.
[Abstract][Full Text][PDF]
Progressive Exercise for Anabolism in Kidney Disease (PEAK): A Randomized, Controlled Trial of Resistance Training during Hemodialysis
Bobby Cheema, Haifa Abas, Benjamin Smith, Anthony O'Sullivan, Maria Chan, Aditi Patwardhan, John Kelly, Adrian Gillin, Glen Pang, Brad Lloyd, and Maria Fiatarone Singh
J. Am. Soc. Nephrol. 2007 18: 1594-1601.
[Abstract][Full Text][PDF]